Laura Iavarone

Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy

Aoibhinn McDonnell, Susie M. Collins, Zahid Ali et al. · Pain · 2018 · 158 citations

Pain Therapy, Pain Medicine, Neuropathic Pain +20

Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach

Manolo Mugnaini, Laura Iavarone, Palmina Cavallini et al. · Neuropsychopharmacology · 2012 · 83 citations · Full text

Substance Abuse, Neuropsychology, Psychoactive Drug +13

Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal‐induced craving

Vincenzo Teneggi, Lisa Squassante, Laura Iavarone et al. · British Journal of Clinical Pharmacology · 2002 · 41 citations · Full text

Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels

Hannah M. Jones, Richard P. Butt, Rob Webster et al. · Clinical Pharmacokinetics · 2016 · 36 citations

Four Selective Inhibitors, Human Pharmacokinetics, Physiology +9

Dose‐Related Reduction in Bupropion Plasma Concentrations by Ritonavir

Joohyun Park, Marika Vousden, Claire Brittain et al. · The Journal of Clinical Pharmacology · 2010 · 34 citations

Drug Interactions, Dosage Adjustment, Repeat Oral Doses +9